4.5 Article

TLR2-, TLR4-and Myd88-independent acquired humoral and cellular immunity against Salmonella enterica serovar Typhimurium

期刊

IMMUNOLOGY LETTERS
卷 127, 期 2, 页码 126-134

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.imlet.2009.10.008

关键词

T cells; Cell differentiation; Inflammation; Gene-deficient mice; Bacterial infection

向作者/读者索取更多资源

Toll-like receptors (TLR) are central to pathogen recognition by the innate immune system. However, their role in the generation of acquired immunity is less clear. Using experimental Salmonella enterica serovar Typhimurium (ST) infection of mice, we determined the role of TLR2, TLR4 and of the TLR adaptor protein Myeloid differentiation factor 88 (MyD88) in the generation of specific T- and B-cell responses against this pathogen. When infected with an attenuated ST strain, mice deficient in TLR4, TLR2 plus TLR4 or MyD88 suffered from exacerbated bacterial burden and delayed clearance. However, all mutant mice not only survived infection but also generated normal antibody responses. Compared to wild-type mice, TLR2+4 deficient mice displayed even enhanced CD4(+) T(H)1 and CD8(+) T cell responses. In contrast, T-cell responses in TLR2 deficient and MyD88 deficient mice were similar to those observed in wild-type controls. Overall, T- and B-cell responses were functional and provided protection against a challenge infection with virulent ST. Our results demonstrate that in the ST infection model, MyD88 as well as TLR2 and TLR4 were largely dispensable for the induction of protective acquired immunity. (C) 2009 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

TRANSVAC research infrastructure - Results and lessons learned from the European network of vaccine research and development

Mark J. Geels, Regitze L. Thogersen, Carlos A. Guzman, Mei Mei Ho, Frank Verreck, Nicolas Collin, James S. Robertson, Samuel J. McConkey, Stefan H. E. Kaufmann, Odile Leroy

VACCINE (2015)

Article Immunology

Molecular signatures for vaccine development

J. Maertzdorf, S. H. E. Kaufmann, J. Weiner

VACCINE (2015)

Article Immunology

High-throughput data analysis and data integration for vaccine trials

January Weiner, Stefan H. E. Kaufmann, Jeroen Maertzdorf

VACCINE (2015)

Article Microbiology

Mycobacterium tuberculosis infection modulates adipose tissue biology

Macarena Beigier-Bompadre, Georgina N. Montagna, Anja A. Kuehl, Laura Lozza, January Weiner, Andreas Kupz, Alexis Vogelzang, Hans-Joachim Mollenkopf, Delia Loewe, Silke Bandermann, Anca Dorhoi, Volker Brinkmann, Kai Matuschewski, Stefan H. E. Kaufmann

PLOS PATHOGENS (2017)

Article Multidisciplinary Sciences

IL-36/LXR axis modulates cholesterol metabolism and immune defense to Mycobacterium tuberculosis

Fadhil Ahsan, Jeroen Maertzdorf, Ute Guhlich-Bornhof, Stefan H. E. Kaufmann, Pedro Moura-Alves

SCIENTIFIC REPORTS (2018)

Article Multidisciplinary Sciences

A Mouse Model of Latent Tuberculosis Infection to Study Intervention Strategies to Prevent Reactivation

Andreas Kupz, Ulrike Zedler, Manuela Staeber, Stefan H. E. Kaufmann

PLOS ONE (2016)

Article Biology

Identification of potential biomarkers of vaccine inflammation in mice

Paul F. McKay, Deniz Cizmeci, Yoann Aldon, Jeroen Maertzdorf, January Weiner, Stefan H. E. Kaufmann, David J. M. Lewis, Robert A. van den Berg, Giuseppe Del Giudice, Robin J. Shattock

Article Cell Biology

FX11 limits Mycobacterium tuberculosis growth and potentiates bactericidal activity of isoniazid through host-directed activity

Gopinath Krishnamoorthy, Peggy Kaiser, Ulrike Abu Abed, January Weiner, Pedro Moura-Alves, Volker Brinkmann, Stefan H. E. Kaufmann

DISEASE MODELS & MECHANISMS (2020)

Review Medicine, Research & Experimental

Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus

Anca Dorhoi, Leigh A. Kotze, Jay A. Berzofsky, Yongjun Sui, Dmitry I. Gabrilovich, Ankita Garg, Richard Hafner, Shabaana A. Khader, Ulrich E. Schaible, Stefan H. E. Kaufmann, Gerhard Walz, Manfred B. Lutz, Robert N. Mahon, Suzanne Ostrand-Rosenberg, William Bishai, Nelita du Plessis

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Immunology

Pregnancy has a minimal impact on the acute transcriptional signature to vaccination

John S. Tregoning, January Weiner, Deniz Cizmeci, Danielle Hake, Jeroen Maertzdorf, Stefan H. E. Kaufmann, Geert Leroux-Roels, Cathy Maes, Annelies Aerssens, Anna Calvert, Christine E. Jones

NPJ VACCINES (2020)

Article Immunology

Weaker protection against tuberculosis in BCG-vaccinated male 129 S2 mice compared to females

Natalie E. Nieuwenhuizen, Joanna Zyla, Ulrike Zedler, Silke Bandermann, Ulrike Abu Abed, Volker Brinkmann, Stefan H. E. Kaufmann

Summary: BCG, the only available vaccine against tuberculosis, was found to have varying efficacy against pulmonary TB based on age and sex. This study revealed that female mice had better protection from BCG vaccination against M. tuberculosis H37Rv challenge, showing lower lung bacterial burdens and less weight loss compared to male mice. It suggests the importance of including both male and female mice in preclinical testing of vaccine candidates.

VACCINE (2021)

Article Biochemistry & Molecular Biology

Vaccine-Induced Subcutaneous Granulomas in Goats Reflect Differences in Host-Mycobacterium Interactions between BCG- and Recombinant BCG-Derivative Vaccines

Elisabeth M. Liebler-Tenorio, Johannes Heyl, Nadine Wedlich, Julia Figl, Heike Koehler, Gopinath Krishnamoorthy, Natalie E. Nieuwenhuizen, Leander Grode, Stefan H. E. Kaufmann, Christian Menge

Summary: This study compares the development of tuberculous granulomas at the site of BCG vaccination and its recombinant derivatives in goats. The results show that granulomas with central caseous necrosis are induced by both BCG and its recombinant derivatives, although the size and extent of necrosis differ between vaccine strains. The recombinant derivatives induce fewer CD4(+) T and B cells and more CD8(+) cells in the granulomas compared to the parental BCG strain. Furthermore, the numbers of multinucleated giant cells (MNGCs) and cells with lipid bodies are significantly lower in groups administered with the recombinant BCG strains. These findings suggest that the granulomas induced by BCG and its recombinant derivatives in goats can serve as suitable models to compare reactions to different mycobacteria or tuberculosis vaccines.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Editorial Material Immunology

100 Years of BCG Immunization: Past, Present, and Future

Aldo Tagliabue, Diana Boraschi, Luciana C. C. Leite, Stefan H. E. Kaufmann

VACCINES (2022)

Article Biochemistry & Molecular Biology

Safety and Immunogenicity of Recombinant Bacille Calmette-Guerin Strain VPM1002 and Its Derivatives in a Goat Model

Julia Figl, Heike Koehler, Nadine Wedlich, Elisabeth M. Liebler-Tenorio, Leander Grode, Gerald Parzmair, Gopinath Krishnamoorthy, Natalie E. Nieuwenhuizen, Stefan H. E. Kaufmann, Christian Menge

Summary: A more effective vaccine against tuberculosis is urgently needed. The recombinant vaccine VPM1002 has been found to be safer and more efficacious than the existing vaccine BCG in mice models. In this study, the safety and immunogenicity of VPM1002 and its derivatives, PDX and NUOG, were assessed in juvenile goats. The results showed that VPM1002 and NUOG induced anti-tuberculous immunity with a comparable safety profile to BCG.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

暂无数据